Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms of the receptor for advanced glycation end products and glyoxalase I and long-term outcome in patients with breast cancer.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Jul 2017

Tesarova Petra, Zima Tomas, Kubena Ales A, Kalousova Marta

Abstract excerpt

Receptor for advanced glycation end products and glyoxalase I metabolizing advanced glycation end product precursors may play important role in the pathogenesis and progression of cancer. Potential relation between soluble forms of receptor for advanced glycation end products (sRAGE), receptor for advanced glycation end products, glyoxalase I polymorphisms, and long-term outcome (median follow-up of 10.3 years)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Kaplan-Meier Estimate

Share to Lactoylglutathione Lyase

Share to Polymorphism, Single Nucleotide

Share to Receptor for Advanced Glycation End Products

Source

Identifiers

PMID: 28695773
DOI: 10.1177/1010428317702902

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms of the receptor for advanced glycation end products and glyoxalase I and long-term outcome in patients with breast cancer.PMID 28695773Read ↗

Receptor for advanced glycation end-product rs1800624 polymorphism contributes to increase breast cancer risk: Evidence from a meta-analysis.Semantic proximity Read ↗

Glyoxalase I Glu111Ala polymorphism in patients with breast cancer.Semantic proximity Read ↗

Association between the receptor for advanced glycation end products gene polymorphisms and cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

Polymorphisms of receptor for advanced glycation end products and risk of epithelial ovarian cancer in Chinese patients.Semantic proximity Read ↗

Pathological Implications of Receptor for Advanced Glycation End-Product (AGER) Gene PolymorphismSemantic proximity Read ↗

Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.Semantic proximity Read ↗

Genetically lowered concentrations of circulating sRAGE might cause an increased risk of cancer: Meta-analysis using Mendelian randomization.Semantic proximity Read ↗

Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies.Semantic proximity Read ↗

Gly82Ser polymorphism of the receptor for advanced glycation end-product (RAGE) potential high risk in patients with colorectal cancer.Semantic proximity Read ↗

Gly82Ser polymorphism of the receptor for advanced glycation end products is associated with an increased risk of gastric cancer in a Chinese population.Semantic proximity Read ↗

The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population.Semantic proximity Read ↗

Effect of RAGE gene polymorphisms and circulating sRAGE levels on susceptibility to gastric cancer: a case–control studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.